A systematic review of outcome reporting in colorectal cancer surgery

Colorectal Disease

Volumn 15, Issue 10, 2013, Pages

  Whistance, R N ^a,b   Forsythe, R O ^a,b   Mcnair, A G K ^a,c   Brookes, S T ^a   Avery, K N L ^a   Pullyblank, A M ^d   Sylvester, P A ^b   Jayne, D G ^e   Jones, J E ^d   Brown, J ^f   Coleman, M G ^g   Dutton, S J ^h   Hackett, R ⁱ   Huxtable, R ^a   Kennedy, R H ^j   Morton, D ^k   Oliver, A ^l   Russell, A ^l   Thomas, M G ^b   Blazeby, J M ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^d NORTH BRISTOL NHS TRUST   (United Kingdom)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^f UNIVERSITY OF LEEDS   (United Kingdom)

^g PLYMOUTH HOSPITALS NHS TRUST   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ Avon   (United Kingdom)

^j ST MARK S HOSPITAL   (United Kingdom)

^k UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^l INSTITUTE OF CANCER RESEARCH   (United Kingdom)

more..

Author keywords

Colorectal cancer; Outcome reporting; Surgery

Indexed keywords

ANASTOMOSIS LEAKAGE; ARTICLE; CANCER SURGERY; CLINICAL RESEARCH; COLORECTAL CANCER; COLORECTAL DISEASE; COLORECTAL SURGERY; DATA ANALYSIS; HUMAN; OUTCOMES RESEARCH; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT OUTCOME; WOUND INFECTION;

COLORECTAL CANCER; OUTCOME REPORTING; SURGERY;

COLORECTAL NEOPLASMS; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; RESEARCH REPORT;

EID: 84886284366     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12378     Document Type: Article

References (105)

1. Guillou PJ, Quirke P, Thorpe H et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre randomised controlled trial. Lancet 2005; 365: 1718-26.
2. Jayne DG, Guillou PJ, Thorpe H et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol 2007; 25: 3061-8.
3. Macfarlane JK, Ryall RDH, Heald RJ. Mesorectal excision for rectal-cancer. Lancet 1993; 341: 457-60.
4. Williamson P, Altman D, Blazeby J et al. Driving up the quality and relevance of research through the use of agreed core outcomes. J Health Serv Res Policy 2012; 17: 1-2.
5. Breukink S, Pierie J, Wiggers T. Laparoscopic versus open total mesorectal excision for rectal cancer. Cochrane Database Syst Rev 2006; 4: CD005200.
6. Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev 2005; 2: CD004323.
7. Spanjersberg WR, Reurings J, Keus F et al. Fast track surgery versus conventional recovery strategies for colorectal surgery. Cochrane Database Syst Rev 2011; 2: CD007635.
8. Kirkham JJ, Dwan KM, Altman DG et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 2010; 340: C365.
9. Speight J, Barendse SM. FDA guidance on patient reported outcomes. BMJ 2010; 340: C2921.
10. Bucher HC, Guyatt GH, Cook DJ et al. Users' guides to the medical literature XIX. Applying clinical trial results a. How to use an article measuring the effect of an intervention on surrogate end points. JAMA 1999; 282: 771-8.
11. Velenik V, Oblak I, Anderluh F. Long-term results from a randomized phase II trial of neoadjuvant combined-modality therapy for locally advanced rectal cancer. Radiat Oncol 2010; 5: 88.
12. Dekker JW, Peeters KC, Putter H et al. Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification. Eur J Surg Oncol 2010; 36: 1180-6.
13. Bulow S, Jensen LH, Altaf R et al. A national cohort study of long-course preoperative radiotherapy in primary fixed rectal cancer in Denmark. Colorectal Dis 2010; 12: E18-23.
14. Zampino MG, Magni E, Leonardi MC et al. Capecitabine initially concomitant to radiotherapy then perioperatively administered in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2009; 75: 421-7.
15. André T, Boni C, Navarro M et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27: 3109-16.
16. Fernández MC, Pericay C, Aparicio J et al. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol 2010; 28: 859-65.
17. Sebag MD, Stephens RJ, Steele R et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373: 811-20.
18. Conde S, Borrego M, Teixeira T et al. Impact of neoadjuvant chemoradiation on pathologic response and survival of patients with locally advanced rectal cancer. Rep Pract Oncol Radiother 2010; 15: 51-9.
19. Khairy T, El HH, Moiety MA. A study evaluating the impact of nerve preserving surgery and adjuvant pelvic irradiation for rectal cancer on quality of life. Chin Ger J Clin Oncol 2010; 9: 459-65.
20. Midgley RS, McConkey CC, Johnstone EC et al. Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial. J Clin Oncol 2010; 28: 4575-80.
21. Jayne DG, Thorpe HC, Copeland J et al. Five-year follow-up of the Medical Research Council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 2010; 97: 1638-45.
22. Buunen M, Veldkamp R, Hop WC et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 2009; 10: 44-52.
23. Roh MS, Colangelo LH, O'Connell MJ et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. JClin Oncol 2009; 27: 5124-30.
24. Stelzner S, Hellmich G, Koch R et al. Exactitude of relative survival compared with cause-specific survival and competing risk estimations based on a clinical database of patients with colorectal carcinoma. Dis Colon Rectum 2009; 52: 1264-71.
25. Devon KM, Vergara-Fernandez O, Victor JC et al. Colorectal cancer surgery in elderly patients: presentation, treatment, and outcomes. Dis Colon Rectum 2009; 52: 1272-7.
26. Lin CC, Lin JK, Chang SC et al. Is adjuvant chemotherapy beneficial to high risk stage II colon cancer? Analysis in a single institute. Int J Colorectal Dis 2009; 24: 665-76.
27. Kornmann M, Staib L, Wiegel T et al. Adjuvant chemoradiotherapy of advanced resectable rectal cancer: results of a randomised trial comparing modulation of 5-fluorouracil with folinic acid or with interferon-alpha. Br J Cancer 2010; 103: 1163-72.
28. Ainsworth PD, Johnson MA. The prognostic significance of the metastatic lymph node ratio in Dukes stage C colorectal cancer in a district general hospital. Colorectal Dis 2010; 12: 1219-22.
29. Ballian N, Yamane B, Leverson G et al. Body mass index does not affect postoperative morbidity and oncologic outcomes of total mesorectal excision for rectal adenocarcinoma. Ann Surg Oncol 2010; 17: 1606-13.
30. Wilkinson NW, Yothers G, Lopa S et al. Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials. Ann Surg Oncol 2010; 17: 959-66.
31. Gort M, Otter R, Plukker JT et al. Actionable indicators for short and long term outcomes in rectal cancer. Eur J Cancer 2010; 46: 1808-14.
32. Min BS, Kim JS, Kim NK et al. Extended lymph node dissection for rectal cancer with radiologically diagnosed extramesenteric lymph node metastasis. Ann Surg Oncol 2009; 16: 3271-8.
33. Bujko K, Kolodziejczyk M, Nasierowska-Guttmejer A et al. Tumour regression grading in patients with residual rectal cancer after preoperative chemoradiation. Radiother Oncol 2010; 95: 298-302.
34. Maluta S, Romano M, Dall'oglio S et al. Regional hyperthermia added to intensified preoperative chemo-radiation in locally advanced adenocarcinoma of middle and lower rectum. Int J Hyperthermia 2010; 26: 108-17.
35. Ychou M, Raoul J-L, Douillard J-Y et al. A phase III randomised trial of LV5FU2+ irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802). Ann Oncol 2009; 20: 674-80.
36. den Dulk DM, Marijnen CA, Collette L et al. Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg 2009; 96: 1066-75.
37. Fields AL, Keller A, Schwartzberg L et al. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer. J Clin Oncol 2009; 27: 1941-7.
38. Quirke P, Steele R, Monson J et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009; 373: 821-8.
39. Bilchik A, Nissan A, Wainberg Z et al. Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer an analysis of 2 international multicenter prospective trials. Ann Surg 2010; 252: 467-76.
40. Ng SSM, Leung KL, Lee JFY et al. Long-term morbidity and oncologic outcomes of laparoscopic-assisted anterior resection for upper rectal cancer: ten-year results of a prospective randomized trial. Dis Colon Rectum 2009; 52: 558-66.
41. Fujii S, Ota M, Ichikawa Y et al. Comparison of short, long-term surgical outcomes and mid-term health-related quality of life after laparoscopic and open resection for colorectal cancer: a case-matched control study. Int J Colorectal Dis 2010; 25: 1311-23.
42. Gollins SW, Myint S, Susnerwala S et al. Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2). Br J Cancer 2009; 101: 924-34.
43. Chen HH, Chakravarty KD, Wang JY et al. Pathological examination of 12 regional lymph nodes and long-term survival in stages I-III colon cancer patients: an analysis of 2, 056 consecutive patients in two branches of same institution. Int J Colorectal Dis 2010; 25: 1333-41.
44. Chin CC, Wang JY, Changchien CR et al. Carcinoma obstruction of the proximal colon cancer and long-term prognosis-obstruction is a predictor of worse outcome in TNM stage II tumor. Int J Colorectal Dis 2010; 25: 817-22.
45. Matthiessen P, Lindgren R, Hallbook O et al. Symptomatic anastomotic leakage diagnosed after hospital discharge following low anterior resection for rectal cancer. Colorectal Dis 2010; 12: E82-7.
46. Bertelsen CA, Andreasen AH, Jorgensen T et al. Anastomotic leakage after curative anterior resection for rectal cancer: short and long-term outcome. Colorectal Dis 2010; 12: E76-81.
47. Telem DA, Chin EH, Nguyen SQ et al. Risk factors for anastomotic leak following colorectal surgery: a case-control study. Arch Surg 2010; 145: 371-6.
48. Kube R, Mroczkowski P, Granowski D et al. Anastomotic leakage after colon cancer surgery: a predictor of significant morbidity and hospital mortality, and diminished tumour-free survival. Eur J Surg Oncol 2010; 36: 120-4.
49. Akiyoshi T, Kuroyanagi H, Oya M et al. Factors affecting the difficulty of laparoscopic total mesorectal excision with double stapling technique anastomosis for low rectal cancer. Surgery 2009; 146: 483-9.
50. Choi DH, Hwang JK, Ko YT et al. Risk factors for anastomotic leakage after laparoscopic rectal resection. J Korean Soc Coloproctol 2010; 26: 265-73.
51. Hyman NH, Osler T, Cataldo P et al. Anastomotic leaks after bowel resection: what does peer review teach us about the relationship to postoperative mortality? J Am Coll Surg 2009; 208: 48-52.
52. Szynglarewicz B, Matkowski R, Forgacz J et al. Restoration of bowel continuity after low anterior rectal cancer resection with a transverse coloplasty pouch: initial clinical findings. Gastroenterol Pol 2009; 16: 365-9.
53. Lujan J, Valero G, Hernandez Q et al. Randomized clinical trial comparing laparoscopic and open surgery in patients with rectal cancer. Br J Surg 2009; 96: 982-9.
54. Pigazzi A, Luca F, Patriti A et al. Multicentric study on robotic tumor-specific mesorectal excision for the treatment of rectal cancer. Ann Surg Oncol 2010; 17: 1614-20.
55. Frye J, Bokey EL, Chapuis PH et al. Anastomotic leakage after resection of colorectal cancer generates prodigious use of hospital resources. Colorectal Dis 2009; 11: 917-20.
56. Biondo S, Ortiz H, Lujan J et al. Quality of mesorectum after laparoscopic resection for rectal cancer - results of an audited teaching programme in Spain. Colorectal Dis 2010; 12: 24-31.
57. Ugolini G, Rosati G, Montroni I et al. Can elderly patients with colorectal cancer tolerate planned surgical treatment? A practical approach to a common dilemma. Colorectal Dis 2009; 11: 750-5.
58. Bisceglia G, Mastrodonato N, Rucci B et al. Effectiveness of neoadjuvant radiotherapy in the treatment of locally advanced rectal cancer: a single-center experience in 263 patients. Dig Surg 2010; 27: 217-23.
59. Jorgren F, Johansson R, Damber L et al. Oncological outcome after incidental perforation in radical rectal cancer surgery. Int J Colorectal Dis 2010; 25: 731-40.
60. Bernstein TE, Endreseth BH, Romundstad P et al. Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg 2009; 96: 1348-57.
61. Huh JW, Kim HR. Postoperative chemotherapy after neoadjuvant chemoradiation and surgery for rectal cancer: is it essential for patients with ypT0-2N0? J Surg Oncol 2009; 100: 387-91.
62. Sigurdsson HK, Korner H, Dahl O et al. Rectal cancer with macroscopic peritoneal involvement-clinical challenges and consequences. Colorectal Dis 2009; 11: 838-44.
63. Martling A, Granath F, Cedermark B et al. Gender differences in the treatment of rectal cancer: a population based study. Eur J Surg Oncol 2009; 35: 427-33.
64. Park JS, Kang SB, Kim DW et al. Laparoscopic versus open resection without splenic flexure mobilization for the treatment of rectum and sigmoid cancer: a study from a single institution that selectively used splenic flexure mobilization. Surg Laparosc Endosc Percutan Tech 2009; 19: 62-8.
65. Park JK, Kim YW, Hur H et al. Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection. Langenbecks Arch Surg 2009; 394: 71-7.
66. Kodeda K, Holmberg E, Steineck G et al. Regional differences in local recurrence rates after rectal cancer surgery. Colorectal Dis 2010; 12: E206-15.
67. Kim JS, Kim NK, Min BS et al. Adjuvant radiotherapy following total mesorectal excision for stage IIA rectal cancer: is it beneficial? Int J Colorectal Dis 2010; 25: 1103-10.
68. Huh JW, Kim YJ, Kim HR. Ratio, of metastatic, to resected lymph nodes as a prognostic factor in node-positive colorectal cancer. Ann Surg Oncol 2010; 17: 2640-6.
69. Jorgren F, Johansson R, Damber L et al. Risk factors of rectal cancer local recurrence: population-based survey and validation of the Swedish rectal cancer registry. Colorectal Dis 2010; 12: 977-86.
70. Elshazly WG, Farouk M, Samy M. Preoperative concomitant radiotherapy with oral capecitabine in advanced rectal cancer within 6 cm from anal verge. Int J Colorectal Dis 2009; 24: 401-7.
71. Kang SB, Park JW, Jeong SY et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 2010; 11: 637-45.
72. Park JS, Choi GS, Lim KH et al. Robotic-assisted versus laparoscopic surgery for low rectal cancer: case-matched analysis of short-term outcomes. Ann Surg Oncol 2010; 17: 3195-202.
73. Lombardi R, Cuicchi D, Pinto C et al. Clinically-staged T3N0 rectal cancer: is preoperative chemoradiotherapy the optimal treatment? Ann Surg Oncol 2010; 17: 838-45.
74. Chen RC, Mamon HJ, Chen Y-H et al. Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancer. Cancer 2010; 116: 1879-86.
75. Jiang J-K, Chen W-S, Wang S-J et al. A novel lifting system for minimally accessed surgery: a prospective comparison between "Laparo-V" gasless and CO2 pneumoperitoneum laparoscopic colorectal surgery. Int J Colorectal Dis 2010; 25: 997-1004.
76. Waters JA, Guzman MJ, Fajardo AD et al. Single-port laparoscopic right hemicolectomy: a safe alternative to conventional laparoscopy. Dis Colon Rectum 2010; 53: 1467-72.
77. Kim YW, Min BS, Kim NK et al. The impact of incorporating of a novice assistant into a laparoscopic team on operative outcomes in laparoscopic sigmoidectomy: a prospective study. Surg Laparosc Endosc Percutan Tech 2010; 20: 36-41.
78. Serra-Aracil X, Bombardo JJ, Moreno MJ et al. Randomized, controlled, prospective trial of the use of a mesh to prevent parastomal hernia. Ann Surg 2009; 249: 583-7.
79. Cabot JC, Lee SA, Yoo J et al. Long-term consequences of not closing the mesenteric defect after laparoscopic right colectomy. Dis Colon Rectum 2010; 53: 289-92.
80. Dent OF, Chapuis PH, Renwick AA et al. The importance of tumor stage and relative survival analysis for the association between sex and survival after resection of colorectal cancer. Ann Surg 2009; 249: 402-8.
81. Gerard JP, Azria D, Gourgou-Bourgade S et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010; 28: 1638-44.
82. Faiz O, Brown T, Colucci G et al. A cohort study of results following elective colonic and rectal resection within an enhanced recovery programme. Colorectal Dis 2009; 11: 366-72.
83. Sammour T, Kahokehr A, Hayes J et al. Warming and humidification of insufflation carbon dioxide in laparoscopic colonic surgery: a double-blinded randomized controlled trial. Ann Surg 2010; 251: 1024-33.
84. Ludwig K, Viscusi ER, Wolff BG et al. Alvimopan for the management of postoperative ileus after bowel resection: characterization of clinical benefit by pooleanalysisd responder. World J Surg 2010; 34: 2185-90.
85. Faiz O, Warusavitarne J, Bottle A et al. Laparoscopically assisted vs. open elective colonic and rectal resection: a comparison of outcomes in English National Health Service Trusts between 1996 and 2006. Dis Colon Rectum 2009; 52: 1695-704.
86. Bennett GE, Pappas TN, Koltun WA et al. Gentamicin-collagen sponge for infection prophylaxis in colorectal surgery. N Engl J Med 2010; 363: 1038-49.
87. Lloyd GM, Kirby R, Hemingway DM et al. The RAPID protocol enhances patient recovery after both laparoscopic and open colorectal resections. Surg Endosc 2010; 24: 1434-9.
88. Al CH, Kavanagh DO, Hassan L et al. The benefit of an enhanced recovery programme following elective laparoscopic sigmoid colectomy. Int J Colorectal Dis 2010; 25: 761-6.
89. Kristjansson SR, Nesbakken A, Jordhoy MS et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol 2010; 76: 208-17.
90. Chikkappa MG, Jagger S, Griffith JP et al. In-house colorectal laparoscopic preceptorship: a model for changing a unit's practice safely and efficiently. Int J Colorectal Dis 2009; 24: 771-6.
91. Lindsetmo R-O, Champagne B, Delaney CP. Laparoscopic rectal resections and fast-track surgery: what can be expected? Am J Surg 2009; 197: 408-12.
92. Hemandas AK, Abdelrahman T, Flashman KG et al. Laparoscopic colorectal surgery produces better outcomes for high risk cancer patients compared to open surgery. Ann Surg 2010; 252: 84-9.
93. Blencowe NS, Strong S, McNair AG et al. Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg 2012; 255: 658-66.
94. Potter S, Brigic A, Whiting PF et al. Reporting clinical outcomes of breast reconstruction: a systematic review. J Natl Cancer Inst 2011; 103: 31-46.
95. Bruce J, Krukowski ZH, Al-Khairy G et al. Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery. Br J Surg 2001; 88: 1157-68.
96. Peel AL, Taylor EW. Proposed definitions for the audit of postoperative infection: a discussion paper. Surgical Infection Study Group. Ann R Coll Surg Engl 1991; 73: 385-8.
97. Punt CJ, Buyse M, Kohne CH et al. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst 2007; 99: 998-1003.
98. Tugwell P, Boers M. OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction. J Rheumatol 1993; 20: 528-30.
99. Tugwell P, Boers M. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee. J Rheumatol 1993; 20: 555-6.
100. Turk DC, Dworkin RH, Allen RR et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003; 106: 337-45.
101. Finer NN, Higgins R, Kattwinkel J et al. Summary proceedings from the apnea-of-prematurity group. Pediatrics 2006; 117: S47-51.
102. Clancy RR. Summary proceedings from the neurology group on neonatal seizures. Pediatrics 2006; 117: S23-7.
103. Sinha IP, Gallagher R, Williamson PR et al. Development of a core outcome set for clinical trials in childhood asthma: a survey of clinicians, parents, and young people. Trials 2012; 13: 103.
104. Sinha IP, Williamson PR, Smyth RL. Outcomes, in clinical trials of inhaled corticosteroids for children with asthma are narrowly focussed on short term disease activity. PLoS ONE 2009; 4: E6276.
105. Reddel HK, Taylor DR, Bateman ED et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations standardising endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180: 59-99.